Details
Stereochemistry | RACEMIC |
Molecular Formula | C20H33N2O |
Molecular Weight | 317.4888 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 1 |
SHOW SMILES / InChI
SMILES
C[N+]1(C)CCN(CC(O)(C2CCCCC2)C3=CC=CC=C3)CC1
InChI
InChIKey=ZRYHPQCHHOKSMD-UHFFFAOYSA-N
InChI=1S/C20H33N2O/c1-22(2)15-13-21(14-16-22)17-20(23,18-9-5-3-6-10-18)19-11-7-4-8-12-19/h3,5-6,9-10,19,23H,4,7-8,11-17H2,1-2H3/q+1
Hexocyclium is an old anticholinergic drug. Hexocyclium is an antimuscarinic. Hexocyclium in therapeutic doses produces a prolonged reduction of gastric acidity. It was used for the treatment of peptic ulcer. Hexocyclium is effective for the control of cramps and diarrhea in cases of irritable bowel syndrome.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
13.0 nM [IC50] | |||
Target ID: CHEMBL211 |
40.0 nM [IC50] | ||
9.0 nM [IC50] | |||
39.0 nM [IC50] | |||
Target ID: CHEMBL2035 Sources: https://www.ncbi.nlm.nih.gov/pubmed/2704370 |
14.0 nM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Tral Approved UseTral is used in the treatment of peptic ulcers. Launch Date1959 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13520691
Single oral doses of 25 mg and 50 mg
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9183081
Acetylcholine-induced concentration-dependent tonic contraction of isolated rat fundus was concentration-dependently antagonized by hexocyclium (KB = 2.82 x 10(-10)M).
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
A03AB10
Created by
admin on Fri Dec 15 15:28:26 GMT 2023 , Edited by admin on Fri Dec 15 15:28:26 GMT 2023
|
||
|
WHO-VATC |
QA03AB10
Created by
admin on Fri Dec 15 15:28:26 GMT 2023 , Edited by admin on Fri Dec 15 15:28:26 GMT 2023
|
||
|
NCI_THESAURUS |
C29704
Created by
admin on Fri Dec 15 15:28:26 GMT 2023 , Edited by admin on Fri Dec 15 15:28:26 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DB06787
Created by
admin on Fri Dec 15 15:28:26 GMT 2023 , Edited by admin on Fri Dec 15 15:28:26 GMT 2023
|
PRIMARY | |||
|
6004-98-4
Created by
admin on Fri Dec 15 15:28:26 GMT 2023 , Edited by admin on Fri Dec 15 15:28:26 GMT 2023
|
PRIMARY | |||
|
24199
Created by
admin on Fri Dec 15 15:28:26 GMT 2023 , Edited by admin on Fri Dec 15 15:28:26 GMT 2023
|
PRIMARY | |||
|
1371
Created by
admin on Fri Dec 15 15:28:26 GMT 2023 , Edited by admin on Fri Dec 15 15:28:26 GMT 2023
|
PRIMARY | |||
|
SUB02515MIG
Created by
admin on Fri Dec 15 15:28:26 GMT 2023 , Edited by admin on Fri Dec 15 15:28:26 GMT 2023
|
PRIMARY | |||
|
C78074
Created by
admin on Fri Dec 15 15:28:26 GMT 2023 , Edited by admin on Fri Dec 15 15:28:26 GMT 2023
|
PRIMARY | |||
|
LL3147PI1T
Created by
admin on Fri Dec 15 15:28:26 GMT 2023 , Edited by admin on Fri Dec 15 15:28:26 GMT 2023
|
PRIMARY | |||
|
26867
Created by
admin on Fri Dec 15 15:28:26 GMT 2023 , Edited by admin on Fri Dec 15 15:28:26 GMT 2023
|
PRIMARY | RxNorm | ||
|
100000086683
Created by
admin on Fri Dec 15 15:28:26 GMT 2023 , Edited by admin on Fri Dec 15 15:28:26 GMT 2023
|
PRIMARY | |||
|
Hexocyclium
Created by
admin on Fri Dec 15 15:28:26 GMT 2023 , Edited by admin on Fri Dec 15 15:28:26 GMT 2023
|
PRIMARY | |||
|
DTXSID80859210
Created by
admin on Fri Dec 15 15:28:26 GMT 2023 , Edited by admin on Fri Dec 15 15:28:26 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)